422 related articles for article (PubMed ID: 22109743)
1. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
Desjardins L; Liabeuf S; Renard C; Lenglet A; Lemke HD; Choukroun G; Drueke TB; Massy ZA;
Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743
[TBL] [Abstract][Full Text] [Related]
2. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
[TBL] [Abstract][Full Text] [Related]
3. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
Kim CS; Bae EH; Ma SK; Han SH; Lee KB; Lee J; Oh KH; Chae DW; Kim SW;
J Korean Med Sci; 2017 Feb; 32(2):240-248. PubMed ID: 28049234
[TBL] [Abstract][Full Text] [Related]
4. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND;
Am J Nephrol; 2020; 51(3):201-215. PubMed ID: 32023606
[TBL] [Abstract][Full Text] [Related]
5. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
Desbiens LC; Sidibé A; Ung RV; Fortier C; Munger M; Wang YP; Bisson SK; Marquis K; Agharazii M; Mac-Way F
Osteoporos Int; 2018 Oct; 29(10):2345-2353. PubMed ID: 29959497
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
Scialla JJ; Lau WL; Reilly MP; Isakova T; Yang HY; Crouthamel MH; Chavkin NW; Rahman M; Wahl P; Amaral AP; Hamano T; Master SR; Nessel L; Chai B; Xie D; Kallem RR; Chen J; Lash JP; Kusek JW; Budoff MJ; Giachelli CM; Wolf M;
Kidney Int; 2013 Jun; 83(6):1159-68. PubMed ID: 23389416
[TBL] [Abstract][Full Text] [Related]
7. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
[TBL] [Abstract][Full Text] [Related]
8. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
Pelletier S; Confavreux CB; Haesebaert J; Guebre-Egziabher F; Bacchetta J; Carlier MC; Chardon L; Laville M; Chapurlat R; London GM; Lafage-Proust MH; Fouque D
Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
[TBL] [Abstract][Full Text] [Related]
9. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
Jovanovich A; Isakova T; Block G; Stubbs J; Smits G; Chonchol M; Miyazaki M
Am J Kidney Dis; 2018 Jan; 71(1):27-34. PubMed ID: 28801122
[TBL] [Abstract][Full Text] [Related]
10. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).
Toussaint ND; Pedagogos E; Lioufas NM; Elder GJ; Pascoe EM; Badve SV; Valks A; Block GA; Boudville N; Cameron JD; Campbell KL; Chen SSM; Faull RJ; Holt SG; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Hooi LS; Narayan O; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Hawley CM;
J Am Soc Nephrol; 2020 Nov; 31(11):2653-2666. PubMed ID: 32917784
[TBL] [Abstract][Full Text] [Related]
12. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart.
Ford ML; Smith ER; Tomlinson LA; Chatterjee PK; Rajkumar C; Holt SG
Nephrol Dial Transplant; 2012 Feb; 27(2):727-33. PubMed ID: 21750158
[TBL] [Abstract][Full Text] [Related]
13. Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis.
Aleksova J; Kurniawan S; Vucak-Dzumhur M; Kerr P; Ebeling PR; Milat F; Elder GJ
Bone; 2018 Aug; 113():118-123. PubMed ID: 29775762
[TBL] [Abstract][Full Text] [Related]
14. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease.
Salam S; Gallagher O; Gossiel F; Paggiosi M; Eastell R; Khwaja A
Bone; 2021 Feb; 143():115699. PubMed ID: 33091638
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
[TBL] [Abstract][Full Text] [Related]
16. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease.
Temmar M; Liabeuf S; Renard C; Czernichow S; Esper NE; Shahapuni I; Presne C; Makdassi R; Andrejak M; Tribouilloy C; Galan P; Safar ME; Choukroun G; Massy Z
J Hypertens; 2010 Jan; 28(1):163-9. PubMed ID: 19927012
[TBL] [Abstract][Full Text] [Related]
17. Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients.
Lee YT; Ng HY; Chiu TT; Li LC; Pei SN; Kuo WH; Lee CT
Clin Chim Acta; 2016 Jan; 452():38-43. PubMed ID: 26522655
[TBL] [Abstract][Full Text] [Related]
18. Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study.
Schoppet M; Hofbauer LC; Brinskelle-Schmal N; Varennes A; Goudable J; Richard M; Hawa G; Chapurlat R; Szulc P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E575-83. PubMed ID: 22319041
[TBL] [Abstract][Full Text] [Related]
19. Uremic toxicity and sclerostin in chronic kidney disease patients.
Desjardins L; Liabeuf S; Oliveira RB; Louvet L; Kamel S; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
Nephrol Ther; 2014 Nov; 10(6):463-70. PubMed ID: 25070604
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3-5D.
Zhang M; Yan J; Zhu M; Ni Z
Ann Clin Lab Sci; 2015; 45(1):17-22. PubMed ID: 25696005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
